Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment
- PMID: 34743790
- PMCID: PMC8636345
- DOI: 10.5664/jcsm.9326
Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment
Abstract
Introduction: This systematic review provides supporting evidence for the accompanying clinical practice guideline on the treatment of central disorders of hypersomnolence in adults and children. The review focuses on prescription medications with U.S. Food & Drug Administration approval and nonpharmacologic interventions studied for the treatment of symptoms caused by central disorders of hypersomnolence.
Methods: The American Academy of Sleep Medicine commissioned a task force of experts in sleep medicine to perform a systematic review. Randomized controlled trials and observational studies addressing pharmacological and nonpharmacological interventions for central disorders of hypersomnolence were identified. Statistical analyses were performed to determine the clinical significance of all outcomes. Finally, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) process was used to assess the evidence for the purpose of making specific treatment recommendations.
Results: The literature search identified 678 studies; 144 met the inclusion criteria and 108 provided data suitable for statistical analyses. Evidence for the following interventions is presented: armodafinil, clarithromycin, clomipramine, dextroamphetamine, flumazenil, intravenous immune globulin (IVIG), light therapy, lithium, l-carnitine, liraglutide, methylphenidate, methylprednisolone, modafinil, naps, pitolisant, selegiline, sodium oxybate, solriamfetol, and triazolam. The task force provided a detailed summary of the evidence along with the quality of evidence, the balance of benefits and harms, patient values and preferences, and resource use considerations.
Citation: Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2021;17(9):1895-1945.
Keywords: Kleine-Levin syndrome; Parkinson’s disease; dementia with lewy bodies; hypersomnia; idiopathic hypersomnia; multiple sclerosis; myotonic dystrophy; narcolepsy; traumatic brain injury; treatment.
© 2021 American Academy of Sleep Medicine.
References
-
- American Academy of Sleep Medicine . International Classification of Sleep Disorders . 3rd ed. Darien, IL: : American Academy of Sleep Medicine; ; 2014. .
-
- Daly DD , Yoss RE . The treatment of narcolepsy with methylphenylpiperidylacetate: a preliminary report . Proc Staff Meet Mayo Clin . 1956. ; 31 ( 23 ): 620 – 625 . - PubMed
-
- American Academy of Sleep Medicine . International Classification of Sleep Disorders: Diagnostic and Coding Manual . 1st ed-revised. Rochester, MN: : American Academy of Sleep Medicine; ; 2001. .
-
- American Academy of Sleep Medicine . International Classification of Sleep Disorders: Diagnostic and Coding Manual . 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005. .
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
